39 / 464
39
Programme and Exhibition Guide |
ESTRO AWARDS
KLAAS BREUR AWARD
Claus Rödel
Department of Radiotherapy and Oncology, University of Frankfurt
Frankfurt, Germany
Claus Rödel (born in 1966) graduated from Erlangen Medical School,
Germany, in 1994, and completed his medical speciality training
degree in radiation oncology in 2002. He was attending physician
and consultant at the Department of Radiation Therapy, University of
Erlangen, Germany, until 2006. In 2007, he was appointed Director
and Chair of the Department of Radiotherapy and Oncology at the
University of Frankfurt, Germany. Since 2008, he has also served as
Clinical Director of the Comprehensive Cancer Centre (UCT) of the
University Hospital of Frankfurt, and is a principal investigator within
the German Cancer Consortium (DKTK). His main research interests
focus on combined modality treatment, including targeted therapies,
for patients with rectal and bladder cancer, as well as molecular
prediction of tumour response. As speaker of the German Rectal
Cancer Study Group he led several phase I-III clinical trials to establish
and optimise chemoradiotherapy for rectal cancer patients. His
scientific work has been honoured with the Herman-Holthusen Award
of the German Society of Radiation Oncologist (DEGRO), the Clinical
Science Award of ARO, and the German Cancer Society’s (DKG)
Award for the best clinical trial in 2015. He also serves as member of
the ESTRO Clinical Committee and is Director of the ESTRO teaching
course for lower gastrointestinal cancers.
Claus Rödel